Aliskiren is a direct renin inhibitor medication that is FDA approved to treat hypertension in adults and children six years and older. It may be used as monotherapy or in combination with other antihypertensive agents. This activity reviews the indications, contraindications, activity, adverse events, mechanism of action, and other critical elements of aliskiren use in hypertension management and highlights the role of the interprofessional team in managing the care of patients receiving therapy with aliskiren.

**Objectives:**
- Identify the mechanism of action of aliskiren.
- Describe the potential adverse effects of aliskiren.
- Summarize the place aliskiren can have in hypertension management, given the current data.
- Explain how interprofessional team collaboration and communication can improve case outcomes in patients who may be on aliskiren therapy for hypertension.